The FDA is allowing Quest Diagnostics to test individual samples for coronavirus using a method known as batch testing, which mixes specimens from multiple people and tests the combined sample for coronavirus instead of testing samples one by one.
The Quest Diagnostics test will be the first in the U.S. with approval for use in batch testing. The FDA is allowing Quest to pool samples of up to four people. Continue reading.